PDB80 WHICH OUTCOME QUALITY MEASURES DO LEADING KOLS WHO TREAT NONALCOHOLIC STEATOHEPATITIS (NASH) RECOMMEND FOR VALUE-BASED CONTRACTING ACROSS MULTIPLE STAKEHOLDERS?
Abstract
Authors
J. Blackham J. Strapp E. Mitchell J. Schwartz